Disorganisation of Retinal Inner Layers (DRIL) in Patients with Diabetic Macular Oedema (DMO)

被引:0
|
作者
Hamill, B. [1 ,2 ,3 ,4 ]
Peto, T. [1 ]
Chakravarthy, U. C. [1 ]
Pearce, I. P. [2 ]
Warburton, J. W. [3 ]
Lupton, S. L. [4 ]
Brown, M. B. [1 ]
机构
[1] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland
[2] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England
[3] Novartis AG, Basel, Switzerland
[4] Novartis Pharmaceut, Frimley, Camberley, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:19 / 19
页数:1
相关论文
共 50 条
  • [41] A UK COST-MINIMISATION ANALYSIS OF BROLUCIZUMAB VERSUS AFLIBERCEPT IN DIABETIC MACULAR OEDEMA (DMO)
    Sydnor, S.
    Ibrahim, M.
    Sing, I
    Vudumula, U.
    Marshall, L.
    Hancock, E.
    Bandeiras, C.
    Felizzi, F.
    VALUE IN HEALTH, 2022, 25 (12) : S135 - S135
  • [42] Retinal vessel dilatation and elongation precedes diabetic macular oedema
    Kristinsson, JK
    Gottfredsdottir, MS
    Stefansson, E
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1997, 81 (04) : 274 - 278
  • [43] COST-EFFECTIVENESS OF FARICIMAB VS AFLIBERCEPT 8MG IN PATIENTS WITH DIABETIC MACULAR OEDEMA (DMO) IN THE UK
    Buhrer, C.
    Bagijn, M.
    Fasci, A.
    Cox, O.
    VALUE IN HEALTH, 2024, 27 (12) : S60 - S60
  • [44] Features associated with retinal thickness extensionin diabetic macular oedema
    Razo Blanco-Hernandez, Dulce Milagros
    Lima-Gomez, Virgilio
    Zuhaila Garcia-Rubio, Yatzul
    CIRUGIA Y CIRUJANOS, 2015, 83 (03): : 183 - 187
  • [45] Identification of diabetic macular oedema using retinal thickness measurements
    Knudsen, Lars Loumann
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (01): : 27 - 31
  • [46] Correlation of retinal sensitivity with retinal thickness and morphological features of diabetic macular oedema
    Comyn, Oliver
    Gohil, Rishma
    Patel, Praveen J.
    Bainbridge, James W. B.
    Hykin, Philip G.
    Sivaprasad, Sobha
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [47] Sleep apnea in diabetic patients with macular oedema
    Truchot, J.
    Margarit, L.
    Pepin, J. L.
    Dupas, B.
    Massin, P.
    Vicaut, E.
    d'Ortho, M. P.
    JOURNAL OF SLEEP RESEARCH, 2014, 23 : 195 - 195
  • [48] Ranibizumab shown to maintain visual gains over three years for patients with visual impairment due to Diabetic Macular Oedema (DMO)
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2012, 14 (11): : 1059 - 1059
  • [49] RELIGHT- RANIBIZUMAB TREATMENT OF DIABETIC MACULAR OEDEMA (DMO) WITH BIMONTHLY MONITORING AFTER INITIAL TREATMENT
    Pearce, I.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2013, 23 (03) : 460 - 460
  • [50] Summary of Research: Cost-Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis
    Buehrer, Christian
    Paling, Thomas
    Gale, Richard
    Paulo, Tatiana
    Bagijn, Marloes
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (08) : 2063 - 2066